Global Heparin Market Growth 2022-2028
As the global economy mends, the 2021 growth of Heparin will have significant change from previous year. According to our latest study, the global Heparin market size is USD million in 2022 from USD 2341.1 million in 2021, with a change of % between 2021 and 2022. The global Heparin market size will reach USD 7388.1 million in 2028, growing at a CAGR of 17.8% over the analysis period.
The United States Heparin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Heparin market, reaching US$ million by the year 2028. As for the Europe Heparin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Heparin players cover Hepalink, Changshan Pharm, Qianhong Bio-pharma, and Opocrin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Heparin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Heparin Sodium Raw Material Drug
Heparin Calcium Raw Material Drug
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Low Molecular Weight Heparin Preparation
Standard Heparin Preparation
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma
Deebio
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heparin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Heparin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Heparin by Country/Region, 2017, 2022 & 2028
2.2 Heparin Segment by Type
2.2.1 Heparin Sodium Raw Material Drug
2.2.2 Heparin Calcium Raw Material Drug
2.3 Heparin Sales by Type
2.3.1 Global Heparin Sales Market Share by Type (2017-2022)
2.3.2 Global Heparin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Heparin Sale Price by Type (2017-2022)
2.4 Heparin Segment by Application
2.4.1 Low Molecular Weight Heparin Preparation
2.4.2 Standard Heparin Preparation
2.5 Heparin Sales by Application
2.5.1 Global Heparin Sale Market Share by Application (2017-2022)
2.5.2 Global Heparin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Heparin Sale Price by Application (2017-2022)
3 Global Heparin by Company
3.1 Global Heparin Breakdown Data by Company
3.1.1 Global Heparin Annual Sales by Company (2020-2022)
3.1.2 Global Heparin Sales Market Share by Company (2020-2022)
3.2 Global Heparin Annual Revenue by Company (2020-2022)
3.2.1 Global Heparin Revenue by Company (2020-2022)
3.2.2 Global Heparin Revenue Market Share by Company (2020-2022)
3.3 Global Heparin Sale Price by Company
3.4 Key Manufacturers Heparin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Heparin Product Location Distribution
3.4.2 Players Heparin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Heparin by Geographic Region
4.1 World Historic Heparin Market Size by Geographic Region (2017-2022)
4.1.1 Global Heparin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Heparin Annual Revenue by Geographic Region
4.2 World Historic Heparin Market Size by Country/Region (2017-2022)
4.2.1 Global Heparin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Heparin Annual Revenue by Country/Region
4.3 Americas Heparin Sales Growth
4.4 APAC Heparin Sales Growth
4.5 Europe Heparin Sales Growth
4.6 Middle East & Africa Heparin Sales Growth
5 Americas
5.1 Americas Heparin Sales by Country
5.1.1 Americas Heparin Sales by Country (2017-2022)
5.1.2 Americas Heparin Revenue by Country (2017-2022)
5.2 Americas Heparin Sales by Type
5.3 Americas Heparin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heparin Sales by Region
6.1.1 APAC Heparin Sales by Region (2017-2022)
6.1.2 APAC Heparin Revenue by Region (2017-2022)
6.2 APAC Heparin Sales by Type
6.3 APAC Heparin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Heparin by Country
7.1.1 Europe Heparin Sales by Country (2017-2022)
7.1.2 Europe Heparin Revenue by Country (2017-2022)
7.2 Europe Heparin Sales by Type
7.3 Europe Heparin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Heparin by Country
8.1.1 Middle East & Africa Heparin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Heparin Revenue by Country (2017-2022)
8.2 Middle East & Africa Heparin Sales by Type
8.3 Middle East & Africa Heparin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Heparin
10.3 Manufacturing Process Analysis of Heparin
10.4 Industry Chain Structure of Heparin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Heparin Distributors
11.3 Heparin Customer
12 World Forecast Review for Heparin by Geographic Region
12.1 Global Heparin Market Size Forecast by Region
12.1.1 Global Heparin Forecast by Region (2023-2028)
12.1.2 Global Heparin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Heparin Forecast by Type
12.7 Global Heparin Forecast by Application
13 Key Players Analysis
13.1 Hepalink
13.1.1 Hepalink Company Information
13.1.2 Hepalink Heparin Product Offered
13.1.3 Hepalink Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hepalink Main Business Overview
13.1.5 Hepalink Latest Developments
13.2 Changshan Pharm
13.2.1 Changshan Pharm Company Information
13.2.2 Changshan Pharm Heparin Product Offered
13.2.3 Changshan Pharm Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Changshan Pharm Main Business Overview
13.2.5 Changshan Pharm Latest Developments
13.3 Qianhong Bio-pharma
13.3.1 Qianhong Bio-pharma Company Information
13.3.2 Qianhong Bio-pharma Heparin Product Offered
13.3.3 Qianhong Bio-pharma Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Qianhong Bio-pharma Main Business Overview
13.3.5 Qianhong Bio-pharma Latest Developments
13.4 Opocrin
13.4.1 Opocrin Company Information
13.4.2 Opocrin Heparin Product Offered
13.4.3 Opocrin Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Opocrin Main Business Overview
13.4.5 Opocrin Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Heparin Product Offered
13.5.3 Pfizer Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Aspen Oss
13.6.1 Aspen Oss Company Information
13.6.2 Aspen Oss Heparin Product Offered
13.6.3 Aspen Oss Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Aspen Oss Main Business Overview
13.6.5 Aspen Oss Latest Developments
13.7 King-friend Biochemical Pharmaceutical
13.7.1 King-friend Biochemical Pharmaceutical Company Information
13.7.2 King-friend Biochemical Pharmaceutical Heparin Product Offered
13.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 King-friend Biochemical Pharmaceutical Main Business Overview
13.7.5 King-friend Biochemical Pharmaceutical Latest Developments
13.8 Bioibérica
13.8.1 Bioibérica Company Information
13.8.2 Bioibérica Heparin Product Offered
13.8.3 Bioibérica Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bioibérica Main Business Overview
13.8.5 Bioibérica Latest Developments
13.9 Dongcheng Biochemicals
13.9.1 Dongcheng Biochemicals Company Information
13.9.2 Dongcheng Biochemicals Heparin Product Offered
13.9.3 Dongcheng Biochemicals Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Dongcheng Biochemicals Main Business Overview
13.9.5 Dongcheng Biochemicals Latest Developments
13.10 Jiulong Biochemicals
13.10.1 Jiulong Biochemicals Company Information
13.10.2 Jiulong Biochemicals Heparin Product Offered
13.10.3 Jiulong Biochemicals Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Jiulong Biochemicals Main Business Overview
13.10.5 Jiulong Biochemicals Latest Developments
13.11 Tiandong
13.11.1 Tiandong Company Information
13.11.2 Tiandong Heparin Product Offered
13.11.3 Tiandong Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Tiandong Main Business Overview
13.11.5 Tiandong Latest Developments
13.12 Xinbai
13.12.1 Xinbai Company Information
13.12.2 Xinbai Heparin Product Offered
13.12.3 Xinbai Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Xinbai Main Business Overview
13.12.5 Xinbai Latest Developments
13.13 Yino Pharma
13.13.1 Yino Pharma Company Information
13.13.2 Yino Pharma Heparin Product Offered
13.13.3 Yino Pharma Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Yino Pharma Main Business Overview
13.13.5 Yino Pharma Latest Developments
13.14 Deebio
13.14.1 Deebio Company Information
13.14.2 Deebio Heparin Product Offered
13.14.3 Deebio Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Deebio Main Business Overview
13.14.5 Deebio Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Heparin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Heparin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Heparin Sodium Raw Material Drug
Table 4. Major Players of Heparin Calcium Raw Material Drug
Table 5. Global Heparin Sales by Type (2017-2022) & (B Units)
Table 6. Global Heparin Sales Market Share by Type (2017-2022)
Table 7. Global Heparin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Heparin Revenue Market Share by Type (2017-2022)
Table 9. Global Heparin Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Heparin Sales by Application (2017-2022) & (B Units)
Table 11. Global Heparin Sales Market Share by Application (2017-2022)
Table 12. Global Heparin Revenue by Application (2017-2022)
Table 13. Global Heparin Revenue Market Share by Application (2017-2022)
Table 14. Global Heparin Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Heparin Sales by Company (2020-2022) & (B Units)
Table 16. Global Heparin Sales Market Share by Company (2020-2022)
Table 17. Global Heparin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Heparin Revenue Market Share by Company (2020-2022)
Table 19. Global Heparin Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Heparin Producing Area Distribution and Sales Area
Table 21. Players Heparin Products Offered
Table 22. Heparin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Heparin Sales by Geographic Region (2017-2022) & (B Units)
Table 26. Global Heparin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Heparin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Heparin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Heparin Sales by Country/Region (2017-2022) & (B Units)
Table 30. Global Heparin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Heparin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Heparin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Heparin Sales by Country (2017-2022) & (B Units)
Table 34. Americas Heparin Sales Market Share by Country (2017-2022)
Table 35. Americas Heparin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Heparin Revenue Market Share by Country (2017-2022)
Table 37. Americas Heparin Sales by Type (2017-2022) & (B Units)
Table 38. Americas Heparin Sales Market Share by Type (2017-2022)
Table 39. Americas Heparin Sales by Application (2017-2022) & (B Units)
Table 40. Americas Heparin Sales Market Share by Application (2017-2022)
Table 41. APAC Heparin Sales by Region (2017-2022) & (B Units)
Table 42. APAC Heparin Sales Market Share by Region (2017-2022)
Table 43. APAC Heparin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Heparin Revenue Market Share by Region (2017-2022)
Table 45. APAC Heparin Sales by Type (2017-2022) & (B Units)
Table 46. APAC Heparin Sales Market Share by Type (2017-2022)
Table 47. APAC Heparin Sales by Application (2017-2022) & (B Units)
Table 48. APAC Heparin Sales Market Share by Application (2017-2022)
Table 49. Europe Heparin Sales by Country (2017-2022) & (B Units)
Table 50. Europe Heparin Sales Market Share by Country (2017-2022)
Table 51. Europe Heparin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Heparin Revenue Market Share by Country (2017-2022)
Table 53. Europe Heparin Sales by Type (2017-2022) & (B Units)
Table 54. Europe Heparin Sales Market Share by Type (2017-2022)
Table 55. Europe Heparin Sales by Application (2017-2022) & (B Units)
Table 56. Europe Heparin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Heparin Sales by Country (2017-2022) & (B Units)
Table 58. Middle East & Africa Heparin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Heparin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Heparin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Heparin Sales by Type (2017-2022) & (B Units)
Table 62. Middle East & Africa Heparin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Heparin Sales by Application (2017-2022) & (B Units)
Table 64. Middle East & Africa Heparin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Heparin
Table 66. Key Market Challenges & Risks of Heparin
Table 67. Key Industry Trends of Heparin
Table 68. Heparin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Heparin Distributors List
Table 71. Heparin Customer List
Table 72. Global Heparin Sales Forecast by Region (2023-2028) & (B Units)
Table 73. Global Heparin Sales Market Forecast by Region
Table 74. Global Heparin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Heparin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Heparin Sales Forecast by Country (2023-2028) & (B Units)
Table 77. Americas Heparin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Heparin Sales Forecast by Region (2023-2028) & (B Units)
Table 79. APAC Heparin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Heparin Sales Forecast by Country (2023-2028) & (B Units)
Table 81. Europe Heparin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Heparin Sales Forecast by Country (2023-2028) & (B Units)
Table 83. Middle East & Africa Heparin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Heparin Sales Forecast by Type (2023-2028) & (B Units)
Table 85. Global Heparin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Heparin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Heparin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Heparin Sales Forecast by Application (2023-2028) & (B Units)
Table 89. Global Heparin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Heparin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Heparin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Hepalink Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 93. Hepalink Heparin Product Offered
Table 94. Hepalink Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Hepalink Main Business
Table 96. Hepalink Latest Developments
Table 97. Changshan Pharm Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 98. Changshan Pharm Heparin Product Offered
Table 99. Changshan Pharm Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Changshan Pharm Main Business
Table 101. Changshan Pharm Latest Developments
Table 102. Qianhong Bio-pharma Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 103. Qianhong Bio-pharma Heparin Product Offered
Table 104. Qianhong Bio-pharma Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Qianhong Bio-pharma Main Business
Table 106. Qianhong Bio-pharma Latest Developments
Table 107. Opocrin Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 108. Opocrin Heparin Product Offered
Table 109. Opocrin Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Opocrin Main Business
Table 111. Opocrin Latest Developments
Table 112. Pfizer Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Heparin Product Offered
Table 114. Pfizer Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Aspen Oss Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 118. Aspen Oss Heparin Product Offered
Table 119. Aspen Oss Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Aspen Oss Main Business
Table 121. Aspen Oss Latest Developments
Table 122. King-friend Biochemical Pharmaceutical Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 123. King-friend Biochemical Pharmaceutical Heparin Product Offered
Table 124. King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. King-friend Biochemical Pharmaceutical Main Business
Table 126. King-friend Biochemical Pharmaceutical Latest Developments
Table 127. Bioibérica Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 128. Bioibérica Heparin Product Offered
Table 129. Bioibérica Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Bioibérica Main Business
Table 131. Bioibérica Latest Developments
Table 132. Dongcheng Biochemicals Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 133. Dongcheng Biochemicals Heparin Product Offered
Table 134. Dongcheng Biochemicals Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Dongcheng Biochemicals Main Business
Table 136. Dongcheng Biochemicals Latest Developments
Table 137. Jiulong Biochemicals Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 138. Jiulong Biochemicals Heparin Product Offered
Table 139. Jiulong Biochemicals Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Jiulong Biochemicals Main Business
Table 141. Jiulong Biochemicals Latest Developments
Table 142. Tiandong Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 143. Tiandong Heparin Product Offered
Table 144. Tiandong Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Tiandong Main Business
Table 146. Tiandong Latest Developments
Table 147. Xinbai Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 148. Xinbai Heparin Product Offered
Table 149. Xinbai Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Xinbai Main Business
Table 151. Xinbai Latest Developments
Table 152. Yino Pharma Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 153. Yino Pharma Heparin Product Offered
Table 154. Yino Pharma Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Yino Pharma Main Business
Table 156. Yino Pharma Latest Developments
Table 157. Deebio Basic Information, Heparin Manufacturing Base, Sales Area and Its Competitors
Table 158. Deebio Heparin Product Offered
Table 159. Deebio Heparin Sales (B Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. Deebio Main Business
Table 161. Deebio Latest Developments
List of Figures
Figure 1. Picture of Heparin
Figure 2. Heparin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Heparin Sales Growth Rate 2017-2028 (B Units)
Figure 7. Global Heparin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Heparin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Heparin Sodium Raw Material Drug
Figure 10. Product Picture of Heparin Calcium Raw Material Drug
Figure 11. Global Heparin Sales Market Share by Type in 2021
Figure 12. Global Heparin Revenue Market Share by Type (2017-2022)
Figure 13. Heparin Consumed in Low Molecular Weight Heparin Preparation
Figure 14. Global Heparin Market: Low Molecular Weight Heparin Preparation (2017-2022) & (B Units)
Figure 15. Heparin Consumed in Standard Heparin Preparation
Figure 16. Global Heparin Market: Standard Heparin Preparation (2017-2022) & (B Units)
Figure 17. Global Heparin Sales Market Share by Application (2017-2022)
Figure 18. Global Heparin Revenue Market Share by Application in 2021
Figure 19. Heparin Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Heparin Revenue Market Share by Company in 2021
Figure 21. Global Heparin Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Heparin Revenue Market Share by Geographic Region in 2021
Figure 23. Global Heparin Sales Market Share by Region (2017-2022)
Figure 24. Global Heparin Revenue Market Share by Country/Region in 2021
Figure 25. Americas Heparin Sales 2017-2022 (B Units)
Figure 26. Americas Heparin Revenue 2017-2022 ($ Millions)
Figure 27. APAC Heparin Sales 2017-2022 (B Units)
Figure 28. APAC Heparin Revenue 2017-2022 ($ Millions)
Figure 29. Europe Heparin Sales 2017-2022 (B Units)
Figure 30. Europe Heparin Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Heparin Sales 2017-2022 (B Units)
Figure 32. Middle East & Africa Heparin Revenue 2017-2022 ($ Millions)
Figure 33. Americas Heparin Sales Market Share by Country in 2021
Figure 34. Americas Heparin Revenue Market Share by Country in 2021
Figure 35. United States Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Heparin Sales Market Share by Region in 2021
Figure 40. APAC Heparin Revenue Market Share by Regions in 2021
Figure 41. China Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Heparin Sales Market Share by Country in 2021
Figure 48. Europe Heparin Revenue Market Share by Country in 2021
Figure 49. Germany Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Heparin Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Heparin Revenue Market Share by Country in 2021
Figure 56. Egypt Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Heparin in 2021
Figure 62. Manufacturing Process Analysis of Heparin
Figure 63. Industry Chain Structure of Heparin
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
